The counterintuitive thing about CBD and senior dogs: older dogs often need less, not more, than younger ones. Slower metabolism means the compound stays in their system longer. That’s actually an advantage. The catch is that senior dogs are also far more likely to be on other medications, which changes the drug interaction picture significantly. If your dog is 8 or older, this guide covers what the research shows, why dosing is different, and what to watch for.
🧪 Lab Tested | 👩💼 Woman-Owned | 🏆 Est. 2017
How Aging Changes Things
Dogs are considered seniors at roughly 7–8 years for large breeds and 10–11 for small ones, though the biology varies significantly by individual. What changes physiologically is directly relevant to how CBD behaves in an older dog’s body.
Liver & kidney function
Both decline with age, slowing the metabolism and excretion of CBD. The same dose that clears a young dog’s system in several hours may persist significantly longer in a senior. This extends effect duration but also increases the window for drug interactions.
Body composition
Senior dogs tend to lose muscle mass and gain fat. Since CBD is fat-soluble, it accumulates in fatty tissue. Higher body fat relative to lean mass can extend how long CBD stays active in the system.
Pain sensitivity
Chronic pain from arthritis and other degenerative conditions becomes more common. The endocannabinoid system plays a role in pain modulation, and aging appears to affect ECS tone, potentially reducing the body’s natural pain buffering capacity.
Medication load
Older dogs are far more likely to be on NSAIDs, phenobarbital, heart medications, or other long-term drugs. CBD is processed by cytochrome P450 liver enzymes, the same pathway used by many prescription medications. The interaction risk rises with every additional drug.
The net effect of slower metabolism: lower starting doses are generally appropriate for seniors, and the time between doses can often be extended compared to what you’d use for a younger dog. “Start low, go slow” applies to any pet, but it matters more once they’re older.
The Mobility Research
The landmark published study on CBD and senior dogs is Gamble et al. 2018, a double-blind, placebo-controlled crossover trial in osteoarthritic dogs (Front Vet Sci, PMID 29736888). Dogs received either CBD oil at 2mg/kg twice daily or placebo for four weeks, then crossed over. The results: pain scores (measured by veterinary assessment) decreased significantly in the CBD group, and owner-assessed mobility improved. No serious adverse effects were observed at this dose.
Three context points matter here. First, all the dogs were already symptomatic; this was a treatment trial in dogs with clinical osteoarthritis, not a prevention trial. Second, the dose (2mg/kg twice daily) is higher than what most owners start with for general wellness. Third, “improved mobility” in a veterinary pain trial means measurable reductions in veterinarian-scored pain scales, not just owner perception, which makes the finding more reliable than anecdotal reports alone.
“I have a 14yr old senior with arthritis and after a few drops he is running around like a puppy again!” Amanda T. “My poor baby has been struggling significantly the past few years with arthritis. I decided to give this a try and it’s helped her sooooo much! She’s still slow but in less pain,” Diana B.
Cognitive Decline and the ECS
Canine cognitive dysfunction syndrome (CCDS) is the veterinary equivalent of dementia. It affects an estimated 14–35% of dogs over 8 years old and produces symptoms recognizable to anyone who has watched a senior dog get confused: disorientation, disrupted sleep, reduced interaction, house-training regression, and what vets describe as “staring at walls” (yes, this is a real clinical sign).
The endocannabinoid system is involved in memory and cognitive function through CB1 receptors in the hippocampus and cortex. Age-related decline in endocannabinoid tone has been documented in mammalian models, and there’s a plausible biological basis for CBD’s potential relevance: by inhibiting FAAH (the enzyme that breaks down anandamide), CBD may help maintain endocannabinoid signaling that declines with age. Direct clinical trials on CBD for CCDS in dogs have not been published yet. The mechanism is real; the clinical evidence specific to canine cognitive decline remains limited.
What CBD does have documented support for in anxious dogs: several owners report significant calming effects, which overlaps with a common CCDS symptom (nighttime restlessness and anxiety). “It works well to calm our elderly dog during a thunder storm,” Susan W. For cognitive decline specifically, CBD is best thought of as a supportive measure rather than a primary treatment; any dog showing signs of cognitive decline should be evaluated by a veterinarian, since CCDS shares symptoms with other treatable conditions.
Dosing for Senior Dogs
The Gamble study used 2mg/kg twice daily for established osteoarthritis. For general wellness or mild discomfort in seniors, most veterinary-oriented resources suggest starting at 0.1–0.3mg/kg once daily and observing for a week before adjusting. TribeTokes Pet CBD Tincture is 300mg per 30mL (10mg/mL), so weight-based dosing is precise with the dropper.
| Senior Dog Weight | Starting Dose | Volume (10mg/mL) | Established Pain Dose* | Volume |
| Under 10 lbs | 0.5–1mg once daily | 0.05–0.1 mL | 1–2mg twice daily | 0.1–0.2 mL |
| 10–25 lbs | 1–2mg once daily | 0.1–0.2 mL | 5–10mg twice daily | 0.5–1.0 mL |
| 25–50 lbs | 2–5mg once daily | 0.2–0.5 mL | 10–20mg twice daily | 1.0–2.0 mL |
| 50–80 lbs | 5–8mg once daily | 0.5–0.8 mL | 20–30mg twice daily | 2.0–3.0 mL |
| Over 80 lbs | 8–12mg once daily | 0.8–1.2 mL | 30–40mg twice daily | 3.0–4.0 mL |
*Established pain dose based on Gamble et al. 2018 (2mg/kg twice daily). Use only under veterinary guidance for dogs on other medications.
The most important rule for senior dogs: give it time before concluding it isn’t working, and give it more time before increasing the dose. Slower metabolism means effects accumulate over days of consistent dosing. Adjusting dose at day three based on “I don’t see anything yet” is too early. A two-week observation window at a stable dose tells you much more than daily micro-adjustments.
Veterinary consultation strongly recommended for seniors on medications. If your dog takes NSAIDs (Rimadyl, Meloxicam), phenobarbital, cyclosporine, or heart medications, CBD’s effect on cytochrome P450 liver enzymes can meaningfully alter drug levels. A vet can check for interactions and recommend whether dose timing changes are needed.
Drug Interactions: The Senior-Specific Risk
CBD is metabolized by cytochrome P450 (CYP450) enzymes in the liver, specifically CYP3A4 and CYP2D6. Many common veterinary medications use the same pathway. When CBD occupies these enzymes, it can reduce the metabolism of other drugs, causing them to accumulate to higher levels than intended. The reverse is also possible: some drugs induce CYP450 enzymes and can accelerate CBD metabolism, reducing its effectiveness.
- NSAIDs (Rimadyl, Meloxicam, Deramaxx): Commonly used for arthritis in the dogs most likely to be given CBD for the same reason. Both are hepatically processed. Monitor liver values if combining long-term.
- Phenobarbital: Used for seizure management. CBD was shown in a 2019 trial (McGrath et al., JAAHA, PMID 31268926) to reduce seizure frequency when added to phenobarbital, but also to raise phenobarbital blood levels, requiring monitoring.
- Cardiac medications (digoxin, atenolol): Senior dogs with heart conditions may be on drugs with narrow therapeutic windows. CYP450 interactions here require veterinary oversight.
- Corticosteroids (prednisone): Commonly used for inflammation and autoimmune conditions. Interaction risk is lower than with the above, but worth disclosing to your vet.
The takeaway is not “don’t use CBD with these medications.” It’s “tell your vet and monitor accordingly.” Many owners successfully combine CBD with veterinary medications under supervision. The risk comes from undisclosed use that prevents proper monitoring.
Signs CBD Might Help
Mobility and comfort
- Reluctance to climb stairs or jump onto furniture
- Stiffness after rest, especially first thing in the morning
- Slow gait or favoring one limb
- Reduced interest in walks or play they previously enjoyed
- Vocalization when moving or being touched in certain areas
Anxiety and cognitive changes
- Nighttime restlessness or pacing
- Increased anxiety around sounds or events that didn’t previously bother them
- Disorientation or seeming “lost” in familiar spaces
- Changes in sleep patterns (sleeping more during day, restless at night)
- Reduced interaction or response to their name
Any of these symptoms in a senior dog warrants a veterinary visit to rule out specific underlying conditions before adding CBD. Some are treatable by other means; others are age-related changes where CBD may offer comfort support alongside veterinary care.
TribeTokes Pet CBD Tincture
Pet Wellness
Pet CBD Tincture For Dogs + Cats
★★★★★ 5.00 from 16 reviews
300mg CBD
Wild Salmon Oil
30mL (10mg/mL)
No THC
Third-Party Tested
300mg CBD in wild salmon oil. No THC (dogs are more sensitive to THC toxicity than humans; their higher CB1 receptor density makes it genuinely risky, not just a precaution). 10mg/mL makes precise weight-based dosing easy with the included dropper, which matters more for seniors where the difference between 1mg and 3mg is meaningful. The salmon oil carrier also delivers EPA and DHA omega-3 fatty acids with their own published support for joint inflammation. COAs at tribetokes.com/certificates-of-analysis.
Frequently Asked Questions
Start at 0.1 to 0.3mg of CBD per kilogram of body weight, once daily. For senior dogs, the starting dose should be lower than what you’d use for a younger dog at the same weight, because slower metabolism means the compound persists longer. For a 50-pound senior dog (about 23kg), 2 to 7mg per day is a reasonable starting range. The Gamble et al. 2018 study used 2mg/kg twice daily specifically for osteoarthritis, which is the higher end of the therapeutic range. Discuss dose with a vet if your dog takes other medications.
A 2018 double-blind, placebo-controlled study (Gamble et al., Front Vet Sci, PMID 29736888) found that CBD at 2mg/kg twice daily reduced veterinarian-assessed pain scores and improved owner-reported mobility in osteoarthritic dogs. This is currently the strongest published clinical evidence for CBD in canine joint conditions. Results vary by individual, and CBD is not a substitute for veterinary diagnosis or treatment of severe arthritis.
It requires veterinary oversight, not avoidance. CBD is metabolized by the same cytochrome P450 liver enzymes as many NSAIDs and other prescription drugs. This can affect blood levels of both compounds. Many owners do use CBD alongside veterinary medications for arthritis successfully, but the vet needs to know so they can monitor liver values and drug levels as appropriate. Don’t add CBD to a senior dog’s regimen without disclosing it to the prescribing vet.
Liver and kidney function decline with age, slowing the metabolism and excretion of CBD. The same dose that clears a young dog’s system in several hours may persist significantly longer in a senior. Combined with higher body fat (where fat-soluble CBD accumulates), this means seniors need less to achieve equivalent blood concentrations. Starting low and observing over two weeks before adjusting avoids inadvertently accumulating too high a dose through daily administration.
Direct clinical trials on CBD for canine cognitive dysfunction syndrome haven’t been published yet. The biological basis is plausible: the endocannabinoid system is involved in memory and cognitive function, and age-related decline in endocannabinoid tone has been documented. CBD may help support ECS signaling through FAAH inhibition. For the anxiety and nighttime restlessness that often accompany cognitive decline, many owners report calming effects. CCDS symptoms overlap with other conditions, so veterinary diagnosis comes first.
Give it two to four weeks of consistent daily use before drawing conclusions. Senior dogs often respond more gradually than younger ones, partly because their metabolism means the compound accumulates slowly over consistent dosing. For joint conditions, the anti-inflammatory effects take time to compound. Evaluating at day three and concluding “nothing happened” misses most of the actual effect window. Keep a simple log of mobility, appetite, and sleep quality to track changes objectively.
No. Dogs have a higher density of CB1 receptors in the cerebellum and brain stem than humans, which makes them significantly more sensitive to THC toxicity. Senior dogs are potentially more vulnerable still, as reduced liver function means slower clearance of THC if ingested. TribeTokes Pet CBD Tincture contains no THC; this is a firm formulation decision, not a regulatory one. The COA confirms the cannabinoid profile for every batch.
Yes, always. Senior dogs are more likely to be on prescription medications where CBD’s effect on CYP450 liver enzymes could alter drug metabolism. Vets need a complete medication list to make safe prescribing decisions and monitor for interactions. Many vets are familiar with CBD in pets and can advise on dose timing, liver monitoring, and whether any of the dog’s current medications are particularly interaction-prone. Concealing supplement use from the vet puts the dog at avoidable risk.
300mg CBD. Precision Dropper. No THC.
Formulated for dogs and cats. Wild salmon oil. 10mg/mL for precise senior dosing. COA on every batch.